USTEKINUMAB
ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
USTEKINUMAB (14944M)
14944M
Manner of administration:Injection
Restriction (Streamlined authority code: 16835)
Indication: Severe chronic plaque psoriasis
Treatment phase: Subsequent continuing treatment, Whole body
Restriction (Streamlined authority code: 16967)
Indication: Severe chronic plaque psoriasis
Treatment phase: Subsequent continuing treatment, Face, hand, foot
